Correlation Between Conduit Pharmaceuticals and Vanda Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Vanda Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Vanda Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Vanda Pharmaceuticals, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Vanda Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Vanda Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Vanda Pharmaceuticals.

Diversification Opportunities for Conduit Pharmaceuticals and Vanda Pharmaceuticals

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Conduit and Vanda is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Vanda Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanda Pharmaceuticals and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Vanda Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanda Pharmaceuticals has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Vanda Pharmaceuticals go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Vanda Pharmaceuticals

Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 12.33 times more return on investment than Vanda Pharmaceuticals. However, Conduit Pharmaceuticals is 12.33 times more volatile than Vanda Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Vanda Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  14.00  in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (12.93) from holding Conduit Pharmaceuticals or give up 92.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy35.56%
ValuesDaily Returns

Conduit Pharmaceuticals  vs.  Vanda Pharmaceuticals

 Performance 
       Timeline  
Conduit Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Vanda Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanda Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Vanda Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Conduit Pharmaceuticals and Vanda Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Conduit Pharmaceuticals and Vanda Pharmaceuticals

The main advantage of trading using opposite Conduit Pharmaceuticals and Vanda Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Vanda Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanda Pharmaceuticals will offset losses from the drop in Vanda Pharmaceuticals' long position.
The idea behind Conduit Pharmaceuticals and Vanda Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas